Clinical Research for Third Parties – CRO specializing in Spain

In the competitive world of pharmaceutical and biotechnology innovation, having a strategic partner in clinical research is essential to ensure the success and safety of projects. Inbiotek, how CRO specialized in Spain, offers a comprehensive, flexible service tailored to the needs of each client, from large pharmaceutical companies to emerging biotech startups.

Our approach is based on scientific excellence, regulatory compliance, and a deep understanding of the European and Spanish regulatory environment.

How do we develop research methods according to your goals?

Each clinical study is unique. In Inbiotek, we understand that standard solutions don't work in a highly specialized environment. Therefore, we design strategies Clinical research for third parties fully customized, aligning with each client's business and scientific objectives.

Evidence-based methodology

• Initial feasibility analysisWe evaluate the feasibility of the clinical study based on inclusion/exclusion criteria, recruitment timelines, and site capacity.
• Optimized Protocol DesignWe collaborate with scientific committees and regulatory authorities to maximize the scientific robustness of the study.
• Comprehensive planning and managementWe offer complete clinical trial lifecycle management, from initial approval to results publication.

Adaptability for startups and large corporations

Whether you are a emerging biotech like a Big pharma, Our team adapts the approach to ensure efficient and cost-effective results.

Custom services for pharmaceutical and biotech companies

How CRO specialized in Spain, in Inbiotek we offer a full range of Clinical research services for pharmaceutical and biotech companies, including:

High-value-added services

• Clinical study design and development
• Medical Device and Medication Records
• Observational studies and post-authorization studies
• Phase I-IV clinical trials
• Translational research
• Clinical and regulatory research consulting
• Regulatory dossier preparation
• Clinical Data Management and Biostatistics
• Clinical Monitoring (CRA)

CRO for biomedical startups

Especially for startups, we offer a flexible, scalable, and budget-friendly service, enabling emerging companies to compete in the international market with high-quality studios.

Clinical research in oncology, cardiology, and medical devices

Inbiotek has proven experience in highly complex therapeutic areas:

Clinical oncology research

Clinical trials in oncology require a deep understanding of biomarkers, targeted therapies, and immuno-oncology. In Inbiotek, we bring:

• Adaptive clinical trial design
• Strategic Selection of Specialized Centers
• Advanced Molecular Data Management

Clinical research in cardiology

From implantable devices to new antiarrhythmic therapies, we manage cardiac clinical studies that meet the highest quality standards.

• Cardiovascular safety monitoring
• Evaluation of Critical Clinical Endpoints
• Integration of digital remote monitoring technologies

CRO specializing in medical devices

The development of medical devices requires a different regulatory approach than that of drugs.

Specific Regulatory Consulting (MDR 2017/745)

• Preclinical and Clinical Study Design
• Evidence-based clinical marketing strategies

Design and execution of custom clinical studies

Designing a successful clinical trial requires more than technical expertise: it demands strategic vision. Inbiotek, we accompany you through all phases:

Design phase

• Identification of primary and secondary objectives
• Endpoint and clinical metrics design
• Development of Standard Operating Procedures (SOPs)

Execution phase

• Recruitment and management of centers
• Quality monitoring and control
• Data Management and Analysis

Closing phase

• Final report writing
• Presentation to Regulatory Authorities
• Publication in high-impact scientific journals

Scientific and regulatory consulting for your biomedical project

The European and Spanish regulatory environment is constantly evolving. Our team of expert consultants in Scientific and regulatory consulting helps you to:

Successfully navigate regulatory requirements

• Successfully navigate EMA and AEMPS requirements
• Optimize your project's regulatory strategy
• Prepare documentation for authorization processes
• Design marketing strategies based on clinical evidence

Conclusion

To choose Inbiotek as your strategic partner in Clinical research for third parties in Spain guarantees you:

• A personalized and flexible approach
• Experience in key therapeutic areas
• Maximum quality and regulatory compliance
• Tailored services for startups, biotech, and large pharmaceutical companies
• Access to a CRO specialized in Spain with international vision